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A 39-residue peptidc (p7-DF) containing the two zinc binding domains of the p7 nucleocapsid protein was prepared by solid-phase peptide synthesis. 
The solution structure of the peptide was characterized using circular dichroic and nuclear magnetic resonance spectroscopy in both the presence 
a,ld absence of zinc ions. Circular dichroic spectroscopy indicates that the peptide xhibits a random coil conformation i the absence of zinc but 
appears to form an ordered structure in the presence of zinc. Two-dimensional uclear magnetic resonance spectroscopy indicates that the two 
zinc binding domains within the peptide form stable, bt, t independent, units upon the addition of 2 equivalents of ZnCi,. per equivalent of peptide. 
Structure calculations on the basis of nuclear Overhauser (NOE) d~ta indicate that the two zinc binding domains have the same polypeptide fold 
within the errors of the coordinates (,~0.5 ~ for the backbone atoms, the zinc atoms and the coordinating cysteine and histidine ligands). The linker 
region (Arg~7-Gly -'~) is characterized by a very limited number of sequential NOEs and the absence of any non-sequential NOEs suggest hat this 
region of" the poIypeptide chain is highly flexible. The latter coupled with the occurrence of a large number of basic residues (four out of seven) 
in the linker region suggests that it may serve to allow adaptable positioning of the nucleic acid recognition sequences within the protein. 
Nucleocapsid protein p7: HIV-I: NMR: Solution structure 
1. INTRODUCTION 
Infectious human immunodeficiency virus type I 
(HIV-I) particles contain almost exclusively unspliced, 
viral genomic RNA [1]. Mutational analysis of viral 
sequences has demonstrated that major cis-acting 
packaging signals are located near the 5' end of the 
RNA, 3' to the splice donor site [2-5] with additional 
packaging signals present in other egions [4,6]. The sole 
n'ans-acting factor required for packaging is the gag 
polyprotein, since mutations in gag frequently prevent 
assembly [7]. The gag precursor polyprotein is cleaved 
into •mature proteins at the time of virus budding, 
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releasing amongst others a 7 kDa nucleocapsid protein 
(p7) which contains a tandem repeat of the Cys-X,-Cys- 
X~- His-X4-Cys sequence motif that is conserved in all 
retroviruses [8,9]. Deletions or changes of these con- 
served cysteine or histidine residues impair or alter 
packaging of RNA into virions [10], supporting the hy- 
pothesis that the retroviral Cys2HisCys motif may be 
important for nucleic acid binding, analogous to tile 
classical Cys_,His= zinc finger motif found in transcrip- 
tion factors. Recently, preferential binding of recom- 
binant HIV-I gag polyprotein to two 200-nucleotide- 
long regions of RNA derived from the 5' end of the gag 
coding region was shown to involve the N-terminal 
Cys_,HisCys motif[l 1]. Although there is still some con- 
troversy about the involvement of zinc in retroviral nu- 
cleocapsid proteins [12,13], it has been shown un, 
ambiguously for the case of HIV-I p7 that protein iso- 
lated fi'am virions, as well as a cloned nucleocapsid 
protein of 140 residues comprising the p7 sequence, 
binds two equivalents of zinc tightly and stoichiometri- 
cally [14,15]. In addition, small retroviral zinc finger- 
like synthetic peptides have been shown to form folded 
domains upon binding ofzinc [16-18]. In this report we 
present a structural investigation by CD and NMR 
spectroscopy of a synthetic 39 residue peptide compris- 
ing residues 13 to 51 of the p7 nucleocapsid protein of 
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HIV-1 and encompassing the two zinc binding domains 
(Fig. 1A) with the aim of assessing the structural simi- 
larity between both domains and of determining 
whether the two domains have a specific spatial orienta- 
tion relative to each other. 
2. MATERIALS AND METHODS 
The 39-residue peptide comprising the two zinc binding domains of 
HIV-I p7 was prepared by solid-phase peptide synthesis [19] on an 
Applied Biosystems (Foster City, CA) 430A peptide synthesizer. Pro- 
tected t-butoxyearbonyl-L-amino acids were purchased from Peptides 
International (Lexington. KE) and protected phenylacetamidemethyl 
resin from Applied Biosystems (Foster City. CA). The final protected 
resin was cleaved using a modified low/high HF cleavage method [20]. 
The extracted peptide (5% aqueous acetic acid/l mM dithiothreitol) 
was purified by gel filtration chromatography ona G-50 (Pharmacia 
Fine Chemicals. Piscataway, N J) column and by HPLC on a Vydae 
(Hesperia, CA) C4-semipreparative (10 mm x 25 cm) reverse-phase 
column. The peptide was eluted from the HPLC column with an 
acetonitrile-water solvent gradient system containing 0.1% trifluoroa. 
cetie acid. and was >95% pure. Identity of the synthetic peptide was 
confirmed by amino acid analysis, as well as by analysis of the NMR 
data. 
CD spectra were recorded from 190 to 260 nm on a Jasco J-500 
spectropolarimeter at 25°C. The peptide 17.5 pM) was dissolved in 
aqueous ZnCI., ( 15/tM) at pH 5.8. The spectra re presented as plots 
of mean residue ellipticity and have been corrected for background 
interference. 
Samples for NMR contained 4.3 mM peptide and 9 mM ZnCI, in 
either 99.996% D~O or 90% H,O/10% D_,O at pH 5.8. The following 
spectra were recorded in both H,O and D,O at 600 MHz on a Bruker 
AM 600 spectrometer at 15°C and 25°C: NOESY [21] (with mixing 
times of 50 and 150 ms). HOHAHA [22] (with mixing times ranging 
from 32 to 55 ms). P.E.COSY [23] and P.COSY [24]. 
3. RESULTS AND DISCUSSION 
The CD spectrum of p7-DF in the absence of zinc is 
characteristic of a random coil conformation (Fig. I B). 
The addition of 2.1 mol of zinc per mol of peptide 
induces a major change in the CD spectra of p7-DF at 
pH 5.8 (Fig. I B). In the presence of zinc a positive 
maximum is observed at ~214 nm, and there is a signif- 
icant decrease in the negative ellipticity as well as a 
snmll red shift of the minimum. This result indicates 
that upon complexation with zinc, the p7-DF peptide 
adopts a different fold from that observed for the free 
peptide. In addition, the NMR spectrum of p7-DF in 
the absence of zinc is characterized by a very narrow 
chemical shift dispersion, confirming that the free pep- 
tide exists in a random conformation (data not shown). 
Subsequent NMR studies were therefore conducted 
with peptide (4.3 raM) in the presence of ZnCI., (9 raM) 
at pH 5.8. 
The complete sequential assignment of the p7-DF 
peptide-Zn complex was accomplished using conven- 
tional 2D NMR methodology [25,26]. To resolve am- 
biguities arising from chemical shift degeneracy, all 
spectra were recorded at two temperatures (15 and 
25°C). Examples of selected regions of the NOESY 
spectrum illustrating NOE connectivities involving the 
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Fig. 1. (A)Amino acid sequence of the pT-DF peptide corresponding 
to positions !3-51 of the p7 nucleoeapsid protein. (B) Circular dichro- 
ism (CD) spectra of p7-DF in the presence (--) and absence ( ..... ) of 
zinc ions. 
backbone NH protons are shown in Fig. 2, a summary 
of the short range NOE data involving the NH. CaH 
and C#H protons is given in Fig. 3, and the complete list 
of assignments i  presented in Table I. 
Qualitative interpretation of the sequential nd short- 
range NOE data presented in Fig. 3 reveals striking 
similarities between the two zinc binding domains 
(Cys3-Cys I~' and Cys24-Cys36), There are NH(i)- 
NH(i+I) cross peaks observed from Cys 3 to Lys ~ and 
from Cys ~ to Lys 29 with the strongest cross peaks oc- 
curring in the regions comprising Asn 5 to Gly 7 and from 
Lys 26 to Gift .  Likewise. NH(i)-NH(i+ 1) connectivities 
from Ala ~3 to Cys  16 in the N-terminal domain are 
matched by the corresponding NOEs in the C-terminal 
one from Met 34 to Cys 37. No NH(i)-NH(i+I) cross 
peaks are observed for the linker region between the two 
domains (Arg =7 to Gly-~~). Medium and long range NOE 
cross peaks also support he view that both domains are 
structurally very similar. Both N-terminal cysteines, 
Cys 3 from the N-terminal domain and Cys ~-4 from the 
C-terminal one, exhibit the same pattern of C/~H(i)- 
NH(i+3, i+4 and i+5) connectivities. The two conserved 
zinc binding histidines, His t~ and His 32, exhibit nume- 
rous connectivities from the imidazole ring protons 
(C~2H and C~tH) to residues i-3 (Lys 8, Lys29), i+4 (Asn is, 
Asp "~') and i+5 (Cys I~. Cys~7), the hitter also being in- 
volved in zinc chelation. 
Interestingly. we did not observe any NOE cross- 
peaks between the two zinc binding domains for any of 
26 
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the conditions used in our NMR experiments. This is 
consistent with the notion of a flexible linker region 
characterized by a paucity of sequential NOEs and no 
non-sequential NOEs. The presence of  a mobile joint 
between the two zinc binding domains of the p7-DF 
peptide is in contrast to solution NMR data obtained 
for a double zinc finger peptide of the classical Cys2His2 
type (J.G.O., G.M.C. and A.M.G.. unpublished data) 
derived from a human enhancer binding protein [27,28] 
and for the two Cys4 zinc binding domains of the gluco- 
corticoid receptor [29]. In both these protein fragments 
the linker region is much more rigid and the two do- 
mains display a specific orientation with respect to each 
other. In addition, results from X-ray diffraction studies 
on a CyszHis, type zinc finger/DNA complex demon- 
strate hydrogen bonding between adjacent fingers [30], 
a feature clearly absent in the p7 peptide structure. 
To obtain a better idea of the polypeptide fold of the 
two zinc binding domains, we proceeded to carry out a 
series of structure calculations on the two separate do- 
mains (residues 1-17 and 22-39) using the hybrid dis- 
tance geometry-simulated annealing method [31]. The 
calculations were based on 147 and 148 approximate 
NOE derived interproton distance restraints for the N- 
and C-terminal domains, respectively, which were clas- 
sified into three ranges, 1.8--2.7 ,A,, 1.8-3.3 ,~ and 1.8-5.0 
,~, corresponding to strong, medium and weak NOEs 
[26]. In addition, tp backbone torsion angle restraints 
( -10 ° to -175 °) were employed to ensure that the ¢ 
angles for all residues, except glycine, were located in 
Table I 
Proton resonance assignments of the p7-DF peptide-zinc complex at 15°C and pH 5.8 
Residue Chemical shift (ppm) ~ 
NH C~H CPH Others 
Val t 3.77 2.01 
Lys 2 8.52 4.41 1.50, 1.44 
Cys ~ 8.31 4.06 2.78, 1.79 
Phe 4 8.84 4.47 3.22, 3.11 
Asn 5 9.56 4.71 3. I0, 2.75 
Cys ¢' 8.83 4.91 3.23, 2.48 
Gly 7 7.94 4.09, 3.77 
Lys X 8.14 4.41 1.87, 1.81 
Glu 9 8.44 4,52 2.1 I. t .86 
Gly I° 8.56 4.47. 3.74 
His tl 7.22 4.80 3.21, 3.21 
Thr ~-" 8,27 4.68 4.48 
Ala L~ 8.93 4.63 1.43 
Arg 14 8.11 4. I0 1.82, 1.69 
Asn ~s 7.93 4.98 3.00. 2.58 
Cys I(' 7.52 3.86 3.34, 2.95 
Arg 17 8.36 4.23 1.85, 1.74 
Ala ~8 8.26 4.54 1.30 
Pro 19 4.24 2.18, 1.78 
Arg ~'° 8.42 4.25 1.78, 1.70 
Lys :t 8.30 4.24 1.78. 1.69 
Lys 2"~ 8.39 4.33 !.77, 1.70 
Gly 2~ 8.24 3.75, 3.56 
Cys ~4 8.17 4.00 2.86, 2.01 
Trp -'-~ 8.60 4.48 3.43.3.40 
Lys ~'(' 9.44 4.25 2.24. 1.66 
Cys ~7 8,69 4.94 3.22, 2.53 
Gly -'~ 8.19 4,07, 3.85 
Lys -'~ 8.47 4.37 1.88, 1.82 
Glu 3° 8,55 4.22 1.99. 1.86 
Gly ~l 8.67 4.34. 3.69 
His "~2 7.14 4.78 3,19, 3.19 
Gln '~'~ 8,95 4.60 1.92, 1.92 
Met 3~ 8.94 4.83 2,15, 2.15 
Lys ~ 8,63 4.24 1.88, 1.73 
Asp ~' 7,94 4.89 2.96, 2.54 
Cys ~7 7.69 3.68 3.29, 2.87 
Thr '~x 8,32 4.45 4.42 
GIu "~'~ 8,62 4.06 2.13, 1.86 
CrH3 0.83, 0.83 
CrH 1.01, 1.01; C'SH !.07, 1.07; C'H 2.86, 2.86 
Call 7.29: C~H 7.34: Cell 7.34 
NH, 8.08; 6.83 
CrH 1.72. 1.72: CSH 1.50, 1.50; C'H 3.02. 3.02 
CrH 2,37. 2.21 
C ~ 7.06; C "~ 7.41 
CH3 1.15 
CrH 1,61, 1.61: Call 3.16.3.16; NH 7.21 
NH 2 7.80. 6.93 
CrH 1.64, 1.64; Call 3.12, 3.12; NH 7.20 
CrH !.93, 1.93: Cell 3.74. 3.54 
CrH 1.58, 1.58: C'~3.08.3.08: NH 7.12 
CrH 1.33, 1.33; C~H 1.55, 1.55: C~H 2.86, 2.86 
CrH 1.41, 1.37; C~H 1.64, 1,64: C~H 2.93, 2.93 
Cr~H 7.34; C'3H 7.60: CdH 10.13; C¢"H 7.50: C¢3H 7.14; C"H 7.23 
CrH 1.31, 1.31; C~H 1.82, 1.82: C~H 2.94, 2.94 
CrH 1.77, 1.60; C6H 1.41, 1.41: C~H 3.02, 3.02 
CrH 2.22. 2.11 
CaSH 6.84; C'lH 7.48 
CYH 2.44, 2.37; NH2 7.66, 6.88 
CrH 2.51, 2.51; C*H.~ 2.09 
CrH 1.22, 1.22; C~H 1.33, 1.33; C'H 3.00, 3.00 
CrH 1.08 
CrH 2.37, 2,21 
;'Chemical shifts are reported relative to 4,4-dimethyl-4-silapentane-l-sulfonate. 
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Fig. 2. (A; NH(Fa axis)-NH(F~ axis) and (B) NH(F, axis)-allphatic (FI axis) regions of the 600 MHz NOESY spectrum (150 ms mixing-time) of 
the p7-DF peptide-Zn complex. A series of N H(i)-NH(i+I) and C"H(i)-NH(i+I) sequential NOE connect ivities are indicated in (A) and (B). 
respectively. Also shown in (B) are some CaH(i)-N H(i+l) NOEs, as well as some non-sequential NOEs involving Cys ~' and Cys 37. Residue labels 
in (B) are at the positions or Ihe intraresidue C~H(i)-NH(i) and C/JH(i)-NH(i) cross-peaks, the latter denoted by the letter,//. The NH(i)-NH(i+ 1) 
cennectivities shown in (A) extend from Phc d to Lys", Ata t'~ to Cys ~', Trp :'~ to Lys :9 and Gin '~3 to Cys :~7. 
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Fig. 3. Summary of short-range NOEs involving the NH. C~H and 
C~H protons, as well as the C~H protons of proline, observed for the 
p7-DF peptide-Zn complex. The NOEs are classified into strong, 
medium and weak according to the thickness of the lines. The C=H 
(Ala~S)-CnH (Pro to) NOE is indicated by the hatched box along the 
same line as the C=H(i)-NH(i+I) NOEs. 
the allowed region of the Ramachandran plot [32]. and 
the coordination geometry of the zinc was restrained to 
be tetrahedral [27]. Initial structure calculations exclud- 
ing the zinc atom indicated unambiguously that the zinc 
had to be coordinated to the N "-" atom of  the histidine 
ligand. The final set of  simulated annealing structures, 
15 for each domain, are not high resolution structures, 
since neither stereospecific assignments nor extensive 
torsion angle restraints were derived from the data [33], 
but are intended to supply information about the poly- 
peptide fold. All the structures atisfy the experimental 
restraints within the errors of  the data (no interproton 
distance violations greater than 0.3 ,&). display very 
small deviations from idealized covalent geometry and 
have good non-bonded contacts. The atomic rms dis- 
tribution of the individual structures about  the mean 
coordinate positions is ~0.5 A for the backbone atoms of 
residues 3/24 to 16/37, the zinc atoms and the cysteine 
and histidine side chains. The atomic rms difference for 
this same set of atoms between the two regularized 
mean structures is 0.47 /~. Thus, the structures of the 
two fingers can be considered to be identical within the 
errors of the present coordinates. A smooth backbone 
atom representation of the two fingers is shown in Fig. 
4A and the dotted line indicates the linker region whose 
conformation is t~ot determined by the data. A superpo- 
sition of  the backbone, the zinc atoms and the histidine 
and cysteine side chains for residues 3/24 to 16/37 of the 
two regularized mean structures is shown in Fig. 4B. 
The structure of the two domains basically consists of 
a fl-hairpin-like structure at the N-terminus containing 
the first two metal bridging cysteines, followed by a 
loop which is tethered to the zinc atom by the histidine 
and last cysteine side chain. 
In summary, the p7-DF peptide, comprising residues 
13-51 of the p7 nucleocapsid protein of HIV-1, is char- 
acterized by a random coil conformation in the absence 
of zinc but forms a highly ordered structure upon addi- 
tion of equimolar amounts of zinc. The solution struc- 
ture of the zinc complex consists of two nearly identical 
zinc binding domains (Cys3-.Cys j~' and Cys24-Cys :~7) 
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Fig. 4. (A) Smooth backbone atom representation f the N- and 
C-terminal zinc binding domains of the p7-DF peptide-Zn complex. 
The linker region from residues 17 to 23, whose conformation could 
not be determined, is shown as a dotted line. (B) Best-fit superposition 
of the regularized mean structures ofthe N- (thick line) and C-terminal 
(thin line) zinc binding domains. 
which are structurally very similar to the single domain 
peptides previously determined by NMR [16,18]. They 
are separated by a very flexible linker segment (Arg ~v- 
Gly 23) which contains four basic residues (2 Arg and 2 
Lys) and a conserved proline. Thus, it may be possible 
that this basic region is involved in contact with the 
nucleic acid. Further experiments are being carried out 
to examine in more detail how the complete p7 recogniz- 
es nucleic acids and exerts its biological effect. 
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